Adage Capital Partners’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Adage Capital Partners’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-32,054	Closed	-$71.2K	–	964
2023 Q4	$71.2K	Sell	32,054 -1	-0%	-$3	﹤0.01%	801
2023 Q3	$168K	Hold	32,055	–	–	﹤0.01%	801
2023 Q2	$226K	Hold	32,055	–	–	﹤0.01%	798
2023 Q1	$305K	Hold	32,055	–	–	﹤0.01%	826
2022 Q4	$195K	Hold	32,055	–	–	﹤0.01%	875
2022 Q3	$444K	Hold	32,055	–	–	﹤0.01%	915
2022 Q2	$1.29M	Hold	32,055	–	–	﹤0.01%	911
2022 Q1	$3.37M	Hold	32,055	–	–	0.01%	865
2021 Q4	$3.69M	Hold	32,055	–	–	0.01%	837
2021 Q3	$12.1M	Buy	32,055 +3,880	+14%	+$1.3M	0.02%	639
2021 Q2	$11.5M	Buy	28,175 +8,175	+41%	+$3.77M	0.02%	653
2021 Q1	$9.54M	Buy	+20,000	New	+$10.9M	0.02%	696

Other funds holding NEXI

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Adage Capital Partners's NEXI Position: Q1 2024 in Review

Adage Capital Partners sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2024, closing a stake of 32,054 shares — an estimated $71.2K sold.

Adage Capital Partners first reported a position in NEXI in Q1 2021 and held it in 12 quarters. The position peaked at $12.1M in Q3 2021. 12 funds tracked by Wall St. Rank hold NEXI as of Q1 2024.

Adage Capital Partners reported no remaining NexImmune, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Adage Capital Partners sold 32,054 NexImmune, Inc. Common Stock shares in Q1 2024, an estimated $71.2K.
Adage Capital Partners first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
Adage Capital Partners's NexImmune, Inc. Common Stock position peaked at $12.1M in Q3 2021.
12 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2024.

Based on Adage Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.